those patients who were held pending the CD34 results. However, it was observed that the lab receipt time for these patients was equivalent to our baseline. Using the HPC parameter and a cutoff of 30, mobilization was adequately predicted 86.4% of the time. For Table 1 n¼66.
Conclusion: Based on these findings, it was determined that this approach for evaluating patient readiness for collection provides an opportunity to reduce time from arrival in the donor room to start of collection. However, further adjustments in communication and scheduling the delivery of the product to the processing laboratory is required to take advantage of the earlier availability of the product. Upon further investigation, the earlier arrival of products coincided with times that had been historically underutilized and had been repurposed for lab meetings and other tasks. This approach does provide an opportunity to reduce downtime in the overall process and better control utilization of resources. Background: Antibody titers from vaccinations administered prior to hematopoietic stem cell transplant (HSCT) for vaccine-preventable diseases (e.g., tetanus, polio) decline 2-5 years after both allogeneic and autologous HSCT. The lack of protective titers to vaccine preventable diseases poses a threat to the immunosuppressed patient population. At Memorial Sloan-Kettering Cancer Center, data indicate that among those eligible to receive vaccination post HSCT, many were not timely immunized or did not receive full recommended series. An immunization clinic for this population was established to increase access, provide timely vaccination administration, and decrease risk to vaccine preventable disease for this population. Population: Patients with leukemia, lymphoma or plasma cell disorders at minimum of 9 months post allogeneic or autologous HSCT, referred by a primary practitioner. Project Description: To establish a centralized clinic led by an advanced practice nurse dedicated to the immunization of the HSCT population. The approach consisted of a multiphase implementation: implementation of standardized treatment guidelines, creation of patient and staff education materials, and the creation and implementation of computer-based data collection systems. Conclusion: Preliminary results of this project demonstrate that the establishment of a centralized immunization clinic increases access to care, improves patient education, and promotes use of standardized guidelines at this institution. This clinic served over 179 HSCT patients, cataloguing 363 unique visits, within its first 12 months of inception. This presentation will include data related to the feasibility of establishing a vaccination clinic as an effective intervention for purposes of increasing access and standardizing evidence-based patient care. Data presented will include the barriers to clinic implementation, rate of vaccination since clinic inception, and the development of a documentation system for data capture related to post HSCT immunization practices. Increasing access and providing comprehensive immunization treatment plans for this patient population may reduce risk to vaccine preventable diseases. 
